JOCS
Journal of Comprehensive Surgery

The aim of the Comprehensive Surgery is to publish original research articles of the highest scientific and clinical value at the international level in all surgical fields. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

eISSN: 2980-0862
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Clinical and ophthalmological findings in patients with Behçet’s uveitis at first presentation
Abstract
Aim: The present study attempted to demonstrate the clinical, demographic, and ophthalmological findings of patients with Behçet’s disease (BD) at first admission and relevant treatment modalities. Methods: We considered 161 eyes of 103 patients applying to the Uvea Unit of Ulucanlar Eye Training and Research Hospital between 2000-2012 and already suffering from BD or diagnosed with BD at their follow-ups. Then, we retrospectively investigated their clinical, demographic, and ophthalmological findings at first admission and the treatment modalities with the help of their medical records. Results: There were 70 (68%) male and 33 (32%) female patients, and 17 patients (16.5%) initially presented with ocular symptoms. While the patients’ mean diagnosis age was 26.79±9.24 years (4-61 years), it was 29.52±9.49 years (6-62 years) at the first eye attack. Eye involvement was bilateral in 58 patients (56.3%) and unilateral in 45 (43.7%). About half of the eyes (55.9%) were presented as panuveitis, 22.4% as posterior uveitis, 15.5% as anterior uveitis, and 6.2% as intermediate uveitis. While there were anterior chamber reaction + vitritis + retinitis and/or vasculitis (panuveitis) in 90 (55.9%) eyes, the others were characterized by isolated retinitis (12.4%) and isolated iridocyclitis (8.7%). Only two eyes (0.1%) had hypopyon at admission. We discovered at least one complication in 111 eyes (68.9%) at first admission. In particular, the most prevalent complication was found to be isolated macular edema in 45 eyes (28%) and isolated cataracts in 17 eyes (10.6%). On the other hand, topical steroid + systemic steroid + immunosuppressive (23.6%), topical + systemic steroid (16.8%), and systemic steroid + immunosuppressive (11.8%) became the most prevalently adopted medical treatments (with additions/alterations) at first admission, respectively. Conclusion: In a nutshell, BD is considered a multisystemic condition with frequent ocular manifestations. BD-associated uveitis often presents as panuveitis. Thus, early and efficient treatment of ocular complications seems to be critical for better visual prognosis.

Keywords : Behçet's disease, first presentation, uveitis

Download Article


1. Michelson JB, Chisari FV. Behçet’s disease. Surv Ophthalmol.1982;26(4):190-203. doi:10.1016/0039-6257(82)90079-0
2. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med.1999;341(17):1284-1291. doi:10.1056/NEJM199910213411707
3. Evereklioglu C. Current concepts in the etiology and treatment ofBehçet disease. Surv Ophthalmol. 2005;50(4):297-350. doi:10.1016/j.survophthal.2005.04.009
4. Mochizuki M, Akduman L, Nussenblatt RB. Behçet’s disease. In:Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular infection andimmunity. St Louis: Mosby, 1996:663-675.
5. Marshall SE. Behçet’s disease. Best Pract Res Clin Rheumatol.2004;18(3):291-311. doi:10.1016/j.berh.2004.02.008
6. Matsuo T, Itami M, Nakagawa H, Nagayama M. The incidence andpathology of conjunctival ulceration in Behçet’s syndrome. Br JOphthalmol. 2002;86(2):140-143. doi:10.1136/bjo.86.2.140
7. Nussenblatt RB, Whitcup SM, Palestine AG. Behc¸et’s disease.In: Nussenblatt RB, Whitcup SM, Palestine AG, editors. Uveitis:fundamentals and clinical practice. St Louis: Mosby, 1996:334-353.
8. Colvard DM, Robertson DM, O’Duffy JD. The ocular manifestations ofBehçet’s disease. Arch Ophthalmol. 1977;95: 1813-1817.
9. Zamir E, Bodaghi B, Tugal-Tutkun I, et al. Conjunctival ulcers in Behçet’s disease. Ophthalmology. 2003;110(6):1137-1141. doi:10.1016/S0161-6420(03)00265-3
10. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H,Urgancioglu M. Uveitis in Behçet disease: an analysis of 880 patients.Am J Ophthalmol. 2004;138(3):373-380. doi:10.1016/j.ajo.2004.03.022
11. Posarelli C, Maglionico MN, Talarico R, Covello G, Figus M. Behçet’ssyndrome and ocular involvement: changes over time. Clin ExpRheumatol. 2020;38 Suppl 127(5):86-93.
12. Ghembaza MEA, Lounici A. Relationship between age at onset andclinical characteristics of Behçet’s disease. Acta Dermatovenerol AlpPannonica Adriat. 2018;27(4):175-177.
13. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization ofUveitis Nomenclature (SUN) Working Group. Standardization ofuveitis nomenclature for reporting clinical data. results of the firstinternational workshop. Am J Ophthalmol. 2005;140(3):509-516.doi:10.1016/j.ajo.2005.03.057
14. Tugal-Tutkun I. Behçet’s uveitis. Middle East Afr J Ophthalmol.2009;16(4):219-224. doi:10.4103/0974-9233.58425
15. Ksiaa I, Abroug N, Kechida M, et al. Eye and Behçet’s disease. J FrOphtalmol. 2019;42(4):e133-e146. doi:10.1016/j.jfo.2019.02.002
16. Nussenblatt RB, Whitcup SW. Uveitis. Fundamentals and clinicalpractice. 3rd ed. St. Louis: Mosby; 2004. p. 350—71.
17. Pathanapitoon K, Kunavisarut P, Saravuttikul FA, Rothova A. Ocularmanifestations and visual outcomes of Behçet’s uveitis in a Thaipopulation. Ocul Immunol Inflamm. 2019;27(1):2-6. doi:10.1080/09273948.2017.1351570
18. Sota J, Cantarini L, Vitale A, et al. Long-term outcomes of Behçet’ssyndrome-related uveitis: a monocentric Italian experience.Mediators Inflamm. 2020;2020:6872402. doi:10.1155/2020/6872402
19. Accorinti M, Pesci FR, Pirraglia MP, Abicca I, Pivetti-Pezzi P. OcularBehçet’s disease: changing patterns over time, complications andlong-term visual prognosis. Ocul Immunol Inflamm. 2017;25(1):29-36. doi:10.3109/09273948.2015.1094095
20. Desbois AC, Terrada C, Cacoub P, Bodaghi B, Saadoun D.Les manifestations oculaires de la maladie de Behçet [Ocularmanifestations in Behçet’s disease]. Rev Med Interne. 2018;39(9):738-745. doi:10.1016/j.revmed.2018.02.022
21. Pathanapitoon K, Kunavisarut P, Saravuttikul FA, Rothova A. Ocularmanifestations and visual outcomes of Behçet’s uveitis in a Thaipopulation. Ocul Immunol Inflamm. 2019;27(1):2-6. doi:10.1080/09273948.2017.1351570
22. Ostrovsky M, Rosenblatt A, Iriqat S, et al. Ocular Behçet disease-clinical manifestations, treatments and outcomes according toage at disease onset. Biomedicines. 2023;11(2):624. doi:10.3390/biomedicines11020624
23. Colvard DM, Robertson DM, O’Duffy JD. The ocular manifestationsof Behçet’s disease. Arch Ophthalmol. 1977;95:1813-1817. doi:10.1001/archopht.1977.04450100115015
24. Krause L, Köhler AK, Altenburg A, et al. Ocular involvement inAdamantiades-Behçet’s disease in Berlin, Germany. Graefes ArchClin Exp Ophthalmol. 2009;247(5):661-666. doi:10.1007/s00417-008-0983-4
Article available in :
Volume 1, Issue 2, 2023
Page : 21-25
https://doi.org/10.51271/JOCS-0006
Article Information
Received : 26 Mar 2023
Accepted : 10 Nis 2023
Published : 28 May 2023
Corresponding Author :

Eyüpcan Şensoy: Ankara Etlik City Hospital, Ankara, Turkey

[email protected]
Citation : Şensoy E, Turan O, Çıtırık M, Berker N. Clinical and ophthalmological findings in patients with Behçet’s uveitis at first presentation. J Compr Surg. 2023;1(2):21-25.

Read: 261
Cited: 0
Download : 199
_Footer